Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin

Cardiovascular Research

Volumn 89, Issue 3, 2011, Pages 650-660

  Rossini, Alessandra ^a,b   Frati, Caterina ^c   Lagrasta, Costanza ^c   Graiani, Gallia ^c   Scopece, Alessandro ^a   Cavalli, Stefano ^c   Musso, Ezio ^c   Baccarin, Marco ^d   Di Segni, Marina ^d   Fagnoni, Francesco ^e   Germani, Antonia ^f   Quaini, Eugenio ^g   Mayr, Manuel ^h   Xu, Qingbo ^h   Barbuti, Andrea ^b   Difrancesco, Dario ^b   Pompilio, Giulio ^a,b   Quaini, Federico ^c   Gaetano, Carlo ⁱ   Capogrossi, Maurizio C ⁱ  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e IRCCS   (Italy)

^f Fondazione Livio Patrizi   (Italy)

^g Osservatorio della Società Italiana di Cardiochirurgia   (Italy)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Cardiac and bone marrow stromal cells; Cardiac regeneration; Cardiovascular differentiation; Myocardial infarction

Indexed keywords

5' NUCLEOTIDASE; ADIPSIN; BETA1 INTEGRIN; CD14 ANTIGEN; CD31 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; INTERLEUKIN 6; MICRORNA; MICROSOMAL AMINOPEPTIDASE; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; THY 1 ANTIGEN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

ADIPOGENESIS; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW STROMAL CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL THERAPY; CONTROLLED STUDY; GENE EXPRESSION; HEART INFARCTION; HEART MUSCLE CELL; HEART STROMAL CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE REGENERATION;

EID: 78751533852     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq290     Document Type: Article

References (35)

1. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119(Pt 11):2204-2213.
2. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 2009;106: 14022-14027.
3. Hou M, Yang KM, Zhang H, Zhu WQ, Duan FJ, Wang H et al. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol 2007;115:220-228.
4. Rossini A, Zacheo A, Mocini D, Totta P, Facchiano A, Castoldi R et al. HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol 2008;44:683-693.
5. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
6. Zaccagnini G, Gaetano C, Della Pietra L, Nanni S, Grasselli A, Mangoni A et al. Tel-omerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J Biol Chem 2005;280:14790-14798.
7. Rosen AB, Kelly DJ, Schuldt AJ, Lu J, Potapova IA, Doronin SV et al. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 2007;25:2128-2138.
8. Lanza R, Moore MA, Wakayama T, Perry AC, Shieh JH, Hendrikx J et al. Regeneration of the infarcted heart with stem cells derived by nuclear transplantation. Circ Res 2004; 94:820-827.
9. Spillmann F, Graiani G, Van Linthout S, Meloni M, Campesi I, Lagrasta C et al. Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium. Regen Med 2006;1:235-254.
10. Montesinos JJ, Flores-Figueroa E, Castillo-Medina S, Flores-Guzman P, Hernandez-Estevez E, Fajardo-Orduna G et al. Human mesenchymal stromal cells from adultand neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Cytotherapy 2009;11:163-176.
11. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3: 301-313.
12. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114: 763-776.
13. Wang J, Chen H, Seth A, McCulloch CA. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2003;285: H1871-H1881.
14. Kaltz N, Funari A, Hippauf S, Delorme B, Noel D, Riminucci M et al. In vivo osteopro-genitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells 2008;26:2419-2424.
15. Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immuno-suppression? Trends Immunol 2007;28:219-226. (Pubitemid 46667240)
16. Blakaj A, Lin H. Piecing together the mosaic of early mammalian development through microRNAs. J Biol Chem 2008;283:9505-9508.
17. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008;15:272-284.
18. Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA et al. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 2010;30:859-868.
19. Ventura C, Cantoni S, Bianchi F, Lionetti V, Cavallini C, Scarlata I et al. Hyaluronan mixed esters of butyric and retinoic Acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J Biol Chem 2007;282:14243-14252.
20. Muller-Ehmsen J, Krausgrill B, Burst V, Schenk K, Neisen UC, Fries JW et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 2006;41: 876-884.
21. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 2005;97:663-673.
22. van der Bogt KE, Schrepfer S, Yu J, Sheikh AY, Hoyt G, Govaert JA et al. Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 2009;87:642-652.
23. McManus KJ, Hendzel MJ. The relationship between histone H3 phosphorylation and acetylation throughout the mammalian cell cycle. Biochem Cell Biol 2006;84: 640-657.
24. Rota M, Padin-Iruegas ME, Misao Y, De Angelis A, Maestroni S, Ferreira-Martins J et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008;103:107-116.
25. Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol 2004;172:1237-1245.
26. McClintock JY, Wagner EM. Role of IL-6 in systemic angiogenesis of the lung. J Appl Physiol 2005;99:861-866.
27. Haniffa MA, Wang XN, Holtick U, Rae M, Isaacs JD, Dickinson AM et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007;179:1595-1604.
28. Lysy PA, Smets F, Sibille C, Najimi M, Sokal EM. Human skin fibroblasts: from meso-dermal to hepatocyte-like differentiation. Hepatology 2007;46:1574-1585.
29. Baertschiger RM, Serre-Beinier V, Morel P, Bosco D, Peyrou M, Clement S et al. Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver. PLoS One 2009;4:e6657.
30. Haniffa MA, Collin MP, Buckley CD, Dazzi F. Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 2009;94:258-263.
31. Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 2000;9:359-368.
32. Fujii T, Yau TM, Weisel RD, Ohno N, Mickle DA, Shiono N et al. Cell transplantation to prevent heart failure: a comparison of cell types. Ann Thorac Surg 2003;76: 2062-2070; discussion 2070.
33. Fuchs M, Hilfiker A, Kaminski K, Hilfiker-Kleiner D, Guener Z, Klein G et al. Role of interleukin-6 for LV remodeling and survival after experimental myocardial infarction. FASEB J 2003;17:2118-2120.
34. Martin-Rendon E, Sweeney D, Lu F, Girdlestone J, Navarrete C, Watt SM. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang 2008;95:137-148.
35. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008;2:313-319.